Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.99% | 10.86% | 10.29% | 12.78% | 12.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.99% | 10.86% | 10.29% | 12.78% | 12.41% |
| Cost of Revenue | 17.86% | 7.86% | 11.34% | 16.34% | 34.37% |
| Gross Profit | 15.18% | 12.15% | 9.60% | 11.48% | 4.99% |
| SG&A Expenses | 12.05% | 10.39% | 4.41% | 1.91% | -2.93% |
| Depreciation & Amortization | -- | -- | -3.21% | 6.28% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.06% | 7.41% | 4.30% | 3.60% | 5.15% |
| Operating Income | 107.86% | 15.46% | 45.89% | 74.85% | 53.99% |
| Income Before Tax | 99.60% | 6.85% | -1,638.86% | -3,688.49% | 82.05% |
| Income Tax Expenses | -22.90% | -87.60% | -1,765.74% | 224.50% | 32.16% |
| Earnings from Continuing Operations | 92.50% | 8.18% | -1,637.30% | -4,915.62% | 80.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.50% | 8.18% | -1,637.30% | -4,915.62% | 80.49% |
| EBIT | 107.86% | 15.46% | 45.89% | 74.85% | 53.99% |
| EBITDA | 225.11% | 35.40% | 149.37% | 270.41% | 168.83% |
| EPS Basic | 92.66% | 10.37% | -1,597.82% | -4,802.27% | 80.92% |
| Normalized Basic EPS | 114.17% | 14.01% | 32.30% | 79.64% | 58.74% |
| EPS Diluted | 92.66% | 10.37% | -1,600.69% | -4,983.72% | 80.92% |
| Normalized Diluted EPS | 114.17% | 14.01% | 32.30% | 79.25% | 58.74% |
| Average Basic Shares Outstanding | 2.49% | 2.45% | 2.32% | 2.30% | 2.28% |
| Average Diluted Shares Outstanding | 2.49% | 2.45% | 2.32% | 0.39% | 2.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |